Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

Share Price is delayed by 15 minutes
Get Live Data
1,717.00    -37.00 (-2.11%)
Bid:
1,715.00
Ask:
1,717.00
Spread: 2.00 (0.117%)
Market Cap: £5.50b
HSX Live PriceLast checked at - London Stock Exchange

Intraday Hiscox Share Chart

Kiskadee update

19 Jan 2015 08:22

RNS Number : 4890C
Hiscox Ltd
19 January 2015
 



 

 

Hiscox announces strong inflows to the Kiskadee ILS Funds

 

 

Hamilton, Bermuda, (19 January, 2015) - Hiscox today announces that total assets under management in its Kiskadee insurance-linked strategies (ILS) funds, have grown to over $400 million at 1 January 2015. Commitments from existing investors have been complemented by strong inflows from new investors, and Kiskadee has also received firm commitments of additional capital for deployment between now and the summer 2015 reinsurance renewal season.

 

The Kiskadee Diversified Fund Ltd and Kiskadee Select Fund Ltd are actively managed open-ended Bermuda domiciled funds. The Kiskadee funds offer investors greater capital efficiency and market access than traditional direct collaterelised ILS funds through their alignment with Hiscox. This structure enables the construction of investible portfolios from a broad and more diverse universe of reinsurance and retrocession risks.

 

Jeremy Pinchin, CEO, Hiscox Re, commented "Our Kiskadee funds combine superior risk selection with diversified market access provided by the Hiscox Group. We believe this is a truly distinctive offering and so are pleased at the enthusiastic response from new and existing investors. Hiscox has a long history of managing alternative forms of capital. Kiskadee is a natural continuation of working with like-minded, long-term partners and offering enhanced solutions to our reinsurance clients."

 

Ends

 

For further information please contact:

Hiscox Ltd

Kylie O'Connor +44 (0) 20 7448 6656 Kylie.O'Connor@HISCOX.com

 

Brunswick

Tom Burns +44 (0) 20 7404 5959 TBurns@brunswickgroup.com 

 

Notes to editors

 

About Kiskadee

Kiskadee Investment Managers, a wholly owned subsidiary of specialist insurer Hiscox, provides investors with the access to the substantial insurance and reinsurance resources of the Hiscox Group. In addition to our flagship Kiskadee Diversified and Kiskadee Select Funds the investment management platform offers single investor funds and bespoke vehicles for tailored insurance, reinsurance portfolios and larger investment allocations.

 

 

About Hiscox

 

Hiscox, the international specialist insurer, is headquartered in Bermuda and listed on the London Stock Exchange (LSE:HSX). There are three main underwriting divisions in the Group - Hiscox London Market, Hiscox Re and Hiscox Retail (which includes Hiscox UK and Europe, Hiscox Guernsey, Hiscox USA and subsidiary brand, DirectAsia). Hiscox underwrites internationally traded, bigger ticket business and reinsurance through Hiscox Re and Hiscox London Market. Through its retail businesses in the UK, Europe and the US Hiscox offers a range of specialist insurance for professionals and business customers, as well as homeowners. For further information, visit www.hiscoxgroup.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCVKLBFEFFLBBF
Date   Source Headline
13th Jan 20236:12 pmRNSAveva Group
7th Dec 20222:21 pmRNSDirector/PDMR Shareholding
1st Dec 202212:45 pmRNSTotal Voting Rights
28th Nov 20227:00 amRNSDirector PDMR Shareholding
14th Nov 202211:08 amRNSSyndicates 33 and 6104 – results and estimates
2nd Nov 20227:00 amRNSQ3 2022 Trading Statement
1st Nov 20224:19 pmRNSTotal Voting Rights
3rd Oct 20225:06 pmRNSTotal Voting Rights
26th Sep 20224:09 pmRNSDirector/PDMR Shareholding
22nd Sep 202211:00 amRNSDirector/PDMR Shareholding
15th Sep 20222:13 pmRNSApplication to be Admitted to the Official List
7th Sep 202212:04 pmRNSAnnouncement of the Scrip Reference Share price
6th Sep 20225:10 pmRNSDirector/PDMR Shareholding
1st Sep 20222:04 pmRNSTotal Voting Rights
12th Aug 20221:38 pmRNSDirector PDMR Shareholding
10th Aug 202212:29 pmRNSSyndicate Results
9th Aug 202211:05 amRNSDirector/PDMR Shareholding
3rd Aug 20227:00 amRNSInterim Report
6th Jul 202211:35 amRNSTotal Voting Rights
15th Jun 20222:05 pmRNSDirector/PDMR Shareholding
9th Jun 20221:09 pmRNSApplication to be Admitted to the Official List
31st May 20223:29 pmRNSAnnouncement of Scrip Reference Share Price
17th May 20225:30 pmRNSDirector/PDMR Shareholding
13th May 20223:30 pmRNSAppointment of Paul Cooper
13th May 20223:15 pmRNSAGM Results
10th May 202210:38 amRNSSyndicates 33 and 6104 – results and estimates
5th May 20227:00 amRNSTrading Statement
3rd May 202212:27 pmRNSTotal Voting Rights
21st Apr 20221:32 pmRNSTR-1 Standard form-notification major shareholding
11th Apr 20224:45 pmRNSNotice of 2022 Annual General Meeting
11th Apr 20222:43 pmRNSDirector/PDMR Shareholding
7th Apr 202211:07 amRNSDirector/PDMR Shareholding
1st Apr 202212:29 pmRNSTotal Voting Rights
29th Mar 20224:47 pmRNSDirector PDMR Shareholding
11th Mar 20224:27 pmRNS2021 Annual Report and Accounts
7th Mar 20226:10 pmRNSDirector/PDMR Shareholding
4th Mar 202210:55 amRNSSyndicates 33 and 6104 – results and estimates
2nd Mar 20227:00 amRNSFull Year Results
1st Mar 202212:15 pmRNSTotal Voting Rights
2nd Feb 20227:42 amRNSTR-1 Standard Form-Notification Major Shareholding
1st Feb 20225:03 pmRNSDirector/PDMR Shareholding
1st Feb 20225:03 pmRNSTotal Voting Rights
4th Jan 20227:00 amRNSTotal Voting Rights
21st Dec 20217:00 amRNSAppointment of Group Chief Financial Officer
13th Dec 20215:54 pmRNSDirector/PDMR Shareholding
6th Dec 20214:20 pmRNSTR-1:Standard form-notification major shareholding
1st Dec 20212:55 pmRNSTotal Voting Rights
22nd Nov 20219:00 amRNSHiscox appoints new Independent Non Exec Director
18th Nov 20219:00 amRNSHiscox announces Liz Breeze as interim Group CFO
2nd Nov 20217:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.